Subtotal $0.00
Information only, not available for purchase.
CagriSema. Regulatory status: Investigational – not FDA-approved.
Availability: Out Of Stock
Combination of cagrilintide and semaglutide in clinical development.
US regulatory status: Investigational – not FDA-approved.
| Regulatory status | Investigational – not FDA-approved |
|---|
Shop Now
Reviews
There are no reviews yet.